UNAIDS. UNAIDS reports on the global AIDS epidemic 2010. 2010; Available from: http://www.unaids.org/globalreport/default.htm
Nel A, Smythe S, Young K, Malcolm K, McCoy C, Rosenberg Z, et al. Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women. J Acquir Immune Defic Syndr. 2009;51(4):416–23.PubMedCrossRef
Friend DR. Pharmaceutical development of microbicide drug products. Pharm Dev Technol. 2010;15(6):562–81.PubMedCrossRef
Romano J, Variano B, Coplan P, Van Roey J, Douville K, Rosenberg Z, et al. Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring. AIDS Res Hum Retrovir. 2009;25(5):483–8.PubMedCrossRef
Tolley EE, Harrison PF, Goetghebeur E, Morrow K, Pool R, Taylor D, et al. Adherence and its measurement in phase 2/3 microbicide trials. AIDS Behav. 2010;14(5):1124–36.PubMedCrossRef
Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.
Merkatz RB, Tokay B, Sitruk-Ware RL. Methods for female contraception: a model for innovation in drug delivery systems. Clin Pharmacol Ther. 2009;85(5):553–7.PubMedCrossRef
Novak A, de la Loge C, Abetz L, van der Meulen EA. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception. 2003;67(3):187–94.PubMedCrossRef
Shimoni N, Westhoff C. Review of the vaginal contraceptive ring (NuvaRing). J Fam Plan Reprod Health Care. 2008;34(4):247–50.CrossRef
Madden T, Blumenthal P. Contraceptive vaginal ring. Clin Obstet Gynecol. 2007;50(4):878–85.PubMedCrossRef
Sabatinia R, Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception. 2006;74:220–3.CrossRef
Nath A, Sitruk-Ware R. Progesterone vaginal ring for contraceptive use during lactation. Contraception. 2010;82(5):428–34.PubMedCrossRef
Hardy E, Hebling EM, Sousa MH, Almeida AF, Amaral E. Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences. Contraception. 2007;76(2):126–31.PubMedCrossRef
Stewart FH, Brown BA, Raine TR, Weitz TA, Harper CC. Adolescent and young women’s experience with the vaginal ring and oral contraceptive pills. J Pediatr Adolesc Gynecol. 2007;20(6):345–51.PubMedCrossRef
Smith DJ, Wakasiaka S, Hoang TD, Bwayo JJ, Del Rio C, Priddy FH. An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population. J Womens Health (Larchmt). 2008;17(6):1025–34.
Woodsong C, Montgomery E, Masenga G, Mollendorf C, Bekker L, Ganesh S, et al., editors. Safety and acceptability of vaginal ring as microbicide delivery method in African women. International partnership for microbicides. Silver Spring, MD; 2010.
Nel A, Young K, Romano J, Woodsong C, van der Straten A, Masenga G, et al. Safety and acceptability of silicone elastomer vaginal rings as potential microbicide delivery method in African women. International partnership for microbicides. Silver Spring, MD; 2011.
Simons-Rudolph A, Woodsong C, Koo H. Modeling the social context of microbicide use. Microbicide Q. 2008;6(4):1–11.
Woodsong C, Alleman P. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. AIDS Educ Prev. 2008;20(2):171–87.PubMedCrossRef
Sahin-Hodoglugil N, Montgomery ET, Kacanek D, Morar NS, Mtetwa S, Nkala B, et al. User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in Southern Africa: a theory based qualitative analysis (under review). 2010.
Woodsong C, Simons-Rudolph A, Alleman P. A comprehensive and flexible conceptual framework for investigating acceptability in microbicide clinical trials (poster presentation). Microbicides 2008. Delhi, India; 2008.
Montgomery ET, van der Straten A, Cheng H, Wenger L, Mesanga G, Rees H, et al. Vaginal ring adherence in sub-saharan Africa: expulsion, removal, and perfect use. International AIDS conference 2011, July 17–20, Rome, Italy 2011.
Bhaduri M, Carr LK, Dunn S, Glanc P. The vaginal ring: expelled or misplaced? J Ultrasound Med. 2009;28(2):259–61.
Kang MS, Buck J, Padian N, Posner SF, Khumalo-Sakutukwa G, van der Straten A. The importance of discreet use of the diaphragm to Zimbabwean women and their partners. AIDS Behav. 2007;11(3):443–51.PubMedCrossRef
Averbach S, Sahin-Hodoglugil N, Musara P, Chipato T, van der Straten A. Duet® for menstrual protection: a feasibility study in Zimbabwe. Contraception. 2009.
Mantell J. Women in the time of AIDS: barriers, bargains, and benefits. AIDS Educ Prev. 2008;20(2):91–106.PubMedCrossRef
Green G, Pool R, Harrison S, Hart GJ, Wilkinson J, Nyanzi S, et al. Female control of sexuality: illusion or reality? Use of vaginal products in south west Uganda. Soc Sci Med. 2001;52(4):585–98.PubMedCrossRef
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Nov 23.
Nel A, Kamupira M, Woodsong C, Montgomery E, Nuttall J, editors. Safety, acceptability, and adherence of monthly dapiravine vaginal microbicide rings for HIV prevention. 19th conference on retroviruses and opportunistic infections (CROI 2012), 2012 March 5–8, 2012, Seattle, WA.
Woodsong C, Shedlin M, Koo H. The ‘natural’ body, God and contraceptive use in the southeastern United States. Culture Health Sex. 2004;6(1):61–78.CrossRef
Stadler J, Saethre E. Blockage and flow: intimate experiences of condoms and microbicides in a South African clinical trial. Culture Health Sex. 2011;13(1):31–44.CrossRef